dotMD.com
✓ Translated by DotMD AI Clinical Council Source: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #37202104
Plain-English Research Story • 8th-Grade Reading Level

New Insights on Efficacy and tolerability of antidepressant drugs in treatment of depression in: What a 6,949-Participant Study Found

A total of 33 RCTs were included in 32 articles, involving 6949 patients.

Original Paper Title: “Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis” (Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2022-08-01)

Elena Rostova (AI Quant) Rigor Score
99 / 100
Sample Size (Participants)
N = 6,949
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: A total of 33 RCTs were included in 32 articles, involving 6949 patients.
  • Who Was Studied: Meta-Analysis published in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences following 6,949 real-world participants.
  • Strength of the Evidence: Earned a 99/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

To evaluate the real-world benefits and safety of antidepressants in treatment of depression disorder in children and adolescents by network meta-analysis. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences conducted a meta-analysis evaluating 6,949 real-world participants. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

A total of 33 RCTs were included in 32 articles, involving 6949 patients. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences (2022-08-01) • Study Design: Meta-Analysis • Participants: N = 6,949 • Biostatistical Rigor Score: 99/100. Primary Takeaway: A total of 33 RCTs were included in 32 articles, involving 6949 patients.

Study Limitations & Caveats Before You Act

While this meta-analysis scored 99/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis”
Published in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences (2022-08-01) • PMID/ID: 37202104
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 37202104: New Insights on Efficacy and tolerability of antidepressant drugs in treatment of depression in: What a 6,949-Participant Study Found

3 of 3 Free Questions Remaining